Pursuant to the provisions of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Jubilant Pharmova has informed that the management of the Company shall be attending Group Meeting on April 5, 2022. The company enclosed details of the Investors/ Analysts for the same and presentation to be used during the Virtual Meet. The schedule may undergo change due to exigencies on the part of Investors/ Analysts/ Company.
The above information is a part of company’s filings submitted to BSE.
